You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1123)
- Medicines safety (501)
- Medical devices safety (342)
- Shortages (77)
- Safety (52)
- Prescription medicines (46)
- Regulatory compliance (18)
- Import and export (16)
- Listed medicines (14)
- Over the counter (OTC) medicines (12)
- Complementary medicines (10)
- Therapeutic goods regulation (10)
- Blood safety (8)
- Non-prescription medicines (6)
- Australian Register of Therapeutic Goods (ARTG) (5)
- Advertising (3)
- Sunscreens (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Type of content
Results for
"[search-keyword]"
Search
1324 result(s) found, displaying 101 to 125
-
Medicine shortage alertsNovo Nordisk Pharmaceuticals has notified the TGA about a critical shortage of the emergency glucagon product GlucaGen HypoKit.
-
Medicine shortage alertsRead about how the shortage of oral cefalexin medicines, that started in December 2022, no longer applies to capsules.
-
Medicine shortage alertsNovo Nordisk Pharmaceuticals has notified the TGA about a shortage of the somatropin products Norditropin FlexPro.
-
Recall actionsMentholatum Australasia Pty Ltd is recalling two batches of Natural Instinct Kids SPF50+ Clean Sunscreen 200mL topical cream and 50mL rollerball products after receiving reports that the sunscreen fluid is splitting into layers.
-
Medicine shortage alertsWe have been notified of a current shortage of Ryzodeg 70/30 FlexTouch insulin prefilled pen, until 5 June 2024.
-
Medicine shortage alertsFind out what the discontinuation of Ordine (morphine) oral liquid means for you.
-
Medicine shortage alertsThe supply of Ozempic (semaglutide) in Australia is improving however the shortage continues. Stay updated about how the shortage impacts you.
-
Safety alertsAustralia tablets pose a serious risk to your health and should not be taken.
-
Safety alertsBig Penis USA tablets pose a serious risk to your health and should not be taken.
-
Safety alertsGermany Niubian tablets pose a serious risk to your health and should not be taken.
-
Safety alertsThe TGA has recently tested the contents of Kamini, and found ingredients in Kamini that pose a serious risk if ingested.
-
Safety alertsUSA Black Gold tablets pose a serious risk to your health and should not be taken.
-
Medicine shortage alertsWe have updated the information about these shortages with new details about affected products and a link to an additional resource for health professionals.
-
Safety alertsA warning about serious kidney damage has been added to the prescribing information for all oral anticoagulants in Australia.
-
Safety alertsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
-
Safety alertsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
-
Safety alertsA safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.
-
Medicine shortage alertsWe continue to monitor antibiotic medicines in shortage and are seeking and prioritising applications for overseas alternatives to assist with supply.
-
Recall actionsMedtronic Australasia is informing customers about the serious risk of valve infolding for EvolutePRO+ 34mm Transcatheter Aortic Valve (TAV), item code - EVPROPLUS-34US.
-
Medicine shortage alertsTo help manage the shortage of the antibiotic phenoxymethylpenicillin (Penicillin V), we have made a Serious Scarcity Substitution Instrument (SSSI).
-
Recall actionsBioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.
-
Medicine shortage alertsThe Metalyse (tenecteplase) shortage is now resolved.
-
Medicine shortage alertsThe TGA is aware of a shortage of all hydrocortisone tablet strengths due to manufacturing issues. We are working with the supplier Alphapharm Pty Ltd to manage the impact.
-
Medicine shortage alertsAs the shortage of Coumadin 5mg tablets is expected to continue, the TGA has made a Serious Scarcity Substitution Instrument to assist patients to access their medicine from their pharmacist without delay or interruption to treatment.
-
Medicine shortage alertsThe TGA is aware of several warfarin product shortages due to manufacturing issues.